Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2006

01-02-2006 | Original Articles

The estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys

Authors: Hataitip Trisomboon, Suchinda Malaivijitnond, Gen Watanabe, Wichai Cherdshewasart, Kazuyoshi Taya

Published in: Endocrine | Issue 1/2006

Login to get access
Metadata
Title
The estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys
Authors
Hataitip Trisomboon
Suchinda Malaivijitnond
Gen Watanabe
Wichai Cherdshewasart
Kazuyoshi Taya
Publication date
01-02-2006
Publisher
Humana Press
Published in
Endocrine / Issue 1/2006
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:29:1:129

Other articles of this Issue 1/2006

Endocrine 1/2006 Go to the issue

OriginalPaper

Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome

Comment

Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism

Original Articles

COX-1 and-2 expressions in sex-related organs of neonatally estrogen-treated rats and in activated and nonactivated macrophage RAW264.7 cells with phytoestrogen

OriginalPaper

Insulin resistance and improvements in signal transduction

OriginalPaper

Diet modification for treatment and prevention of obesity

Original Articles

Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits